• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WTAP与肝细胞癌的不良预后、肿瘤细胞增殖及免疫浸润相关。

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma.

作者信息

Liang Linjun, Xu Hongfa, Dong Qichao, Qiu Lige, Lu Ligong, Yang Qing, Zhao Wei, Li Yong

机构信息

Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.

Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China.

出版信息

Front Oncol. 2022 Apr 11;12:852000. doi: 10.3389/fonc.2022.852000. eCollection 2022.

DOI:10.3389/fonc.2022.852000
PMID:35480109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9035869/
Abstract

WTAP is involved in various pathological and physiological processes, but its function in hepatocellular carcinoma (HCC) remains elusive. In this study, we investigated the role of WTAP in HCC. Firstly, the mRNA and protein of WTAP were expressed highly in HCC tissue, which reflected clinicopathological characteristics of HCC patients. Then, an interactive analysis of genetic profiles and Kaplan-Meier curves was performed to show that WTAP was an independent predictor of survival of HCC patients. Meanwhile, genes co-expressed with WTAP, potential protein-protein interactions, related signaling pathways, and immune cell infiltration were identified. It was found that high WTAP expression correlated with enhanced interactions between cytokines and their receptors, cell cycle, and chemokine signaling pathways, as well as increased immune cell infiltration. At last, WTAP knockdown experiments indicate that the WTAP silencing inhibited HCC proliferation and aggressiveness. We conclude that WTAP may be a novel biomarker for prognosis and a therapeutic target for HCC.

摘要

WTAP参与多种病理和生理过程,但其在肝细胞癌(HCC)中的功能仍不清楚。在本研究中,我们调查了WTAP在HCC中的作用。首先,WTAP的mRNA和蛋白在HCC组织中高表达,这反映了HCC患者的临床病理特征。然后,进行了基因图谱和Kaplan-Meier曲线的交互分析,结果表明WTAP是HCC患者生存的独立预测因子。同时,鉴定了与WTAP共表达的基因、潜在的蛋白质-蛋白质相互作用、相关信号通路和免疫细胞浸润。研究发现,WTAP高表达与细胞因子及其受体之间增强的相互作用、细胞周期和趋化因子信号通路以及免疫细胞浸润增加相关。最后,WTAP敲低实验表明,WTAP沉默抑制了HCC的增殖和侵袭性。我们得出结论,WTAP可能是一种新的预后生物标志物和HCC的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/a3eb018222d8/fonc-12-852000-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/8d1a94211c95/fonc-12-852000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/fce5150202c0/fonc-12-852000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/fd41ab2239cd/fonc-12-852000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/77367f991f58/fonc-12-852000-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/4ee296b76403/fonc-12-852000-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/8ab3d3e9b567/fonc-12-852000-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/a3eb018222d8/fonc-12-852000-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/8d1a94211c95/fonc-12-852000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/fce5150202c0/fonc-12-852000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/fd41ab2239cd/fonc-12-852000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/77367f991f58/fonc-12-852000-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/4ee296b76403/fonc-12-852000-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/8ab3d3e9b567/fonc-12-852000-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f378/9035869/a3eb018222d8/fonc-12-852000-g007.jpg

相似文献

1
WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma.WTAP与肝细胞癌的不良预后、肿瘤细胞增殖及免疫浸润相关。
Front Oncol. 2022 Apr 11;12:852000. doi: 10.3389/fonc.2022.852000. eCollection 2022.
2
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.WTAP 通过 m6A-HuR 依赖的 ETS1 表观遗传沉默促进肝细胞癌进展。
Mol Cancer. 2019 Aug 22;18(1):127. doi: 10.1186/s12943-019-1053-8.
3
High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.WTAP 高表达通过影响肿瘤相关 T 淋巴细胞浸润导致胃癌预后不良。
J Cell Mol Med. 2020 Apr;24(8):4452-4465. doi: 10.1111/jcmm.15104. Epub 2020 Mar 16.
4
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.PDZ 结合激酶高表达与肝癌预后不良和免疫浸润相关。
World J Surg Oncol. 2022 Jan 22;20(1):22. doi: 10.1186/s12957-021-02479-w.
5
Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer.WTAP在泛癌中的预后及免疫作用的综合分析
Front Genet. 2022 Sep 6;13:1007696. doi: 10.3389/fgene.2022.1007696. eCollection 2022.
6
Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.鉴定 CDC20 作为肝癌免疫浸润相关的预后生物标志物。
Invest New Drugs. 2021 Oct;39(5):1439-1453. doi: 10.1007/s10637-021-01126-1. Epub 2021 May 3.
7
Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.肝细胞癌中 COMMD 蛋白家族的表达、预后价值和免疫浸润活性的转录分析。
BMC Cancer. 2021 Sep 7;21(1):1001. doi: 10.1186/s12885-021-08699-3.
8
Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.全面分析肝细胞癌中 N6-甲基腺苷相关的长非编码 RNA 与免疫细胞浸润。
Bioengineered. 2021 Dec;12(1):1708-1724. doi: 10.1080/21655979.2021.1923381.
9
Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.免疫浸润相关血清淀粉样蛋白 A1 预测肝细胞癌预后良好。
World J Gastroenterol. 2020 Sep 21;26(35):5287-5301. doi: 10.3748/wjg.v26.i35.5287.
10
CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.CXCL2/10/12/14 是肝癌的预后生物标志物,与免疫浸润相关。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20204312.

引用本文的文献

1
Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10.肝细胞和巨噬细胞中Tfap2a的缺失通过调节SREBP1/FASN/ACC途径和IL10的抗炎作用促进肝细胞癌进展。
Cell Death Dis. 2025 Apr 3;16(1):245. doi: 10.1038/s41419-025-07500-8.
2
WTAP regulates Mitochondrial damage and Lipid oxidation in HCC by NOA1 mediated m6A modification.WTAP通过NOA1介导的m6A修饰调节肝癌中的线粒体损伤和脂质氧化。
J Cancer. 2025 Jan 1;16(1):315-330. doi: 10.7150/jca.102618. eCollection 2025.
3
The diverse landscape of RNA modifications in cancer development and progression.

本文引用的文献

1
Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miR-425-5p Inhibits Acute Myeloid Leukemia Cell Proliferation, Apoptosis, Invasion and Migration by Targeting WTAP.骨髓间充质干细胞来源的外泌体miR-425-5p通过靶向WTAP抑制急性髓系白血病细胞的增殖、凋亡、侵袭和迁移。
Onco Targets Ther. 2021 Sep 24;14:4901-4914. doi: 10.2147/OTT.S286326. eCollection 2021.
2
miR-139-5p Loss-Mediated WTAP Activation Contributes to Hepatocellular Carcinoma Progression by Promoting the Epithelial to Mesenchymal Transition.miR-139-5p缺失介导的WTAP激活通过促进上皮-间质转化促进肝细胞癌进展。
Front Oncol. 2021 Apr 15;11:611544. doi: 10.3389/fonc.2021.611544. eCollection 2021.
3
癌症发生和发展过程中RNA修饰的多样图景。
Genes Genomics. 2025 Feb;47(2):135-155. doi: 10.1007/s13258-024-01601-y. Epub 2024 Dec 6.
4
The Emerging, Multifaceted Role of WTAP in Cancer and Cancer Therapeutics.WTAP在癌症及癌症治疗中新兴的多方面作用
Cancers (Basel). 2023 Jun 4;15(11):3053. doi: 10.3390/cancers15113053.
5
Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.缺氧反应性 PPARGC1A/BAMBI/ACSL5 轴促进肝癌的进展和对乐伐替尼的耐药性。
Oncogene. 2023 May;42(19):1509-1523. doi: 10.1038/s41388-023-02665-y. Epub 2023 Mar 17.
6
Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.WTAP 在癌症中的作用:从机制到治疗潜力。
Biomolecules. 2022 Sep 2;12(9):1224. doi: 10.3390/biom12091224.
WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an mA-dependent manner.
WTAP 通过依赖 mA 的方式抑制 HMBOX1 表达促进骨肉瘤肿瘤发生。
Cell Death Dis. 2020 Aug 19;11(8):659. doi: 10.1038/s41419-020-02847-6.
4
The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.N6-甲基腺苷(m6A)失调在肝癌发生中的新作用。
Mol Cancer. 2020 Feb 28;19(1):44. doi: 10.1186/s12943-020-01172-y.
5
Memory T cell, exhaustion, and tumor immunity.记忆性T细胞、耗竭与肿瘤免疫。
Immunol Med. 2020 Mar;43(1):1-9. doi: 10.1080/25785826.2019.1698261. Epub 2019 Dec 10.
6
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy.肿瘤微环境中的免疫细胞:在癌症免疫治疗中的生物学功能和作用。
Cancer Lett. 2020 Feb 1;470:126-133. doi: 10.1016/j.canlet.2019.11.009. Epub 2019 Nov 12.
7
Landscape and Regulation of mA and mAm Methylome across Human and Mouse Tissues.人类和小鼠组织中 mA 和 mAm 甲基组的景观和调控。
Mol Cell. 2020 Jan 16;77(2):426-440.e6. doi: 10.1016/j.molcel.2019.09.032. Epub 2019 Oct 29.
8
m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.m6A去甲基化酶FTO通过介导丙酮酸激酶M2(PKM2)去甲基化促进肝细胞癌的肿瘤发生。
Am J Transl Res. 2019 Sep 15;11(9):6084-6092. eCollection 2019.
9
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.WTAP 通过 m6A-HuR 依赖的 ETS1 表观遗传沉默促进肝细胞癌进展。
Mol Cancer. 2019 Aug 22;18(1):127. doi: 10.1186/s12943-019-1053-8.
10
RNA modifications modulate gene expression during development.RNA 修饰在发育过程中调节基因表达。
Science. 2018 Sep 28;361(6409):1346-1349. doi: 10.1126/science.aau1646.